13S155: Abstracts: Metabolic and Crystal Arthropathies – Basic and Clinical Science (1579–1584)

Abstract Moderator(s)

• MT

  Michael Toprover, MD

  New York University Langone Health
  New York, NY, United States

  Disclosure(s): ANI Pharmaceuticals: Consultant (Ongoing); Horizon Pharma: Consultant (Terminated, March 1, 2021)
• 

  Natalie McCormick, PhD, MSc

  Massachusetts General Hospital
  Boston, MA, United States

  Disclosure(s): No financial relationships to disclose

Oral abstract session.

Presentations:

• 3:00 PM – 3:10 PM Eastern Time

  The TICOG Study: Tight Control of Gout - A Randomized, Controlled Trial of Targeted versus Conventional Treatment for Gout Including Ultrasonography
  

  Presenting Author: Sarah Black, MD – Musgrave Park Hospital, Belfast Health and Social Care Trust
• 3:10 PM – 3:15 PM Eastern Time

  Q&A
  
• 3:15 PM – 3:25 PM Eastern Time

  Poor Serum Urate Control Is a Driver of Excess Cardiovascular Risk in Patients with Gout
  

  Presenting Author: Tate Johnson, MD – University of Nebraska Medical Center
• 3:25 PM – 3:30 PM Eastern Time

  Q&A
  
• 3:30 PM – 3:40 PM Eastern Time

  Presence of Sonographic Crystal Deposits and Power-Doppler Signal in Patients with Gout Fulfilling Remission Criteria: A Multicenter Study
  

  Presenting Author: Mariano Andrés, PhD – Dr Balmis Alicante General University Hospital-ISABIAL
• 3:40 PM – 3:45 PM Eastern Time

  Q&A
  
• 3:45 PM – 3:55 PM Eastern Time

  Allopurinol Use and Risk of Acute Coronary Syndrome in Patients with Incident Gout: A Population-based Study in Sweden
  

  Presenting Author: Panagiota Drivelegka, MD, PhD – Department of Rheumatology, Sahlgrenska University hospital
• 3:55 PM – 4:00 PM Eastern Time

  Q&A
  
• 4:00 PM – 4:10 PM Eastern Time

  Race and Disease Severity Predict Reduced Response to Treat-to-Target Urate Lowering Therapy in Gout: Post-hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial
  

  Presenting Author: Lindsay Helget, MD – University of Nebraska Medical Center
• 4:10 PM – 4:15 PM Eastern Time

  Q&A
  
• 4:15 PM – 4:25 PM Eastern Time

  Colchicine or Prednisone for the Treatment of Acute Calcium Pyrophosphate Deposition Arthritis: A Multicenter Randomized Controlled Trial
  

  Presenting Author: Tristan Pascart, MD, PhD – Groupement Hospitalier de l'Institut Catholique de Lille
• 4:25 PM – 4:30 PM Eastern Time

  Q&A